A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

ProgenaBiome

Status: Withdrawn

Conditions: Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa Simplex; Epidermolysis Bullosa

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04213703

PRG-034

Details and patient eligibility

About

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Full description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to Epidermolysis Bullosa

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study i. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
2. Male or female of all ages. (interest is given to children who present with autism or Crohn's and whose parents wish to analyze their children's gut flora. Also of interest analysis of development of the child's microbiome. In the case of autism, the younger the child, the better to correct the neurological problems if an association is found between autism and the microbiome)
3. Diagnosis of Epidermolysis by at least one of the following i. Biopsy ii. Genetic testing

Exclusion criteria

1. Refusal to sign informed consent form
2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
3. Postoperative stoma, ostomy, or ileoanal pouch
4. Participation in any experimental drug protocol within the past 12 weeks
5. Treatment with total parenteral nutrition

Trial design

0 participants in 1 patient group

Patients with Epidermolysis Bullosa

Description:

Patients who have been diagnosed with Epidermolysis Bullosa

Treatment:

Other: No intervention